PTGS2 and pancreatic ductal adenocarcinoma: In COX-2-expressing pancreatic ductal adenocarcinoma, increased levels of PGE2 induced resistance against γδ T cell cytotoxicity, which was restored by the co-treatment with COX-2 inhibitor DuP697 and tribody [(Her2)2×Vγ9] [106].